Physician profile
Phillip E Noel
NPI 1477550499
$1,389.00
in general payments reported to CMS, 2019-2025
10 companies · $328 in 2025
The $328 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $77.25 · 2020: $139 · 2021: $29.28 · 2022: $351 · 2023: $219 · 2024: $245 · 2025: $328.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $692 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $692.04 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aerin Medical INC. | $455.33 | 2019-2024 | |
| Jazz Pharmaceuticals INC. | $301.13 | 2021-2024 | |
| Allergan, INC. | $217.94 | 2022 | |
| Avadel Cns Pharmaceuticals, LLC | $136.62 | 2024-2025 | Lumryz |
| Inspire Medical Systems, INC. | $117.49 | 2023-2025 | Inspire |
| Genzyme Corporation | $53.46 | 2025 | |
| Optinose US, INC. | $44.50 | 2025 | |
| Stryker Corporation | $23.30 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $22.73 | 2025 | Dupixent |
| Olympus America INC. | $16.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Phillip Noel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.